| Primary |
| Immunodeficiency Common Variable |
46.5% |
| Hypogammaglobulinaemia |
17.0% |
| Immunodeficiency |
9.6% |
| Primary Immunodeficiency Syndrome |
4.6% |
| Blood Immunoglobulin G Decreased |
3.5% |
| Selective Igg Subclass Deficiency |
3.5% |
| Combined Immunodeficiency |
2.5% |
| Immune System Disorder |
1.4% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
1.1% |
| Chronic Lymphocytic Leukaemia |
1.1% |
| Epstein-barr Virus Infection |
1.1% |
| Humoral Immune Defect |
1.1% |
| Immunosuppression |
1.1% |
| Infection |
1.1% |
| Polyneuropathy |
1.1% |
| Selective Polysaccharide Antibody Deficiency |
1.1% |
| Axonal Neuropathy |
0.7% |
| Hypoproteinaemia |
0.7% |
| Immunisation |
0.7% |
| Immunoglobulins Decreased |
0.7% |
|
| Vomiting |
11.1% |
| Urticaria |
10.4% |
| Meningitis Aseptic |
8.9% |
| Transmission Of An Infectious Agent Via A Medicinal Product |
6.7% |
| Dyspnoea |
5.2% |
| Headache |
5.2% |
| Weight Decreased |
5.2% |
| Pain In Extremity |
4.4% |
| Wrong Technique In Drug Usage Process |
4.4% |
| Death |
3.7% |
| Deep Vein Thrombosis |
3.7% |
| Nausea |
3.7% |
| Oedema Peripheral |
3.7% |
| Pyrexia |
3.7% |
| Vasculitis |
3.7% |
| Visual Impairment |
3.7% |
| Wheezing |
3.7% |
| Blood Glucose Increased |
3.0% |
| Convulsion |
3.0% |
| Hepatitis B Surface Antigen Positive |
3.0% |
|
| Secondary |
| Immunodeficiency Common Variable |
46.5% |
| Hypogammaglobulinaemia |
9.7% |
| Product Used For Unknown Indication |
8.0% |
| Immunodeficiency |
6.9% |
| Humoral Immune Defect |
6.5% |
| Primary Immunodeficiency Syndrome |
5.2% |
| Blood Immunoglobulin G Decreased |
3.4% |
| Premedication |
2.4% |
| Immune System Disorder |
1.9% |
| Selective Igg Subclass Deficiency |
1.9% |
| Asthma |
1.3% |
| Respiratory Tract Infection |
1.1% |
| Combined Immunodeficiency |
0.9% |
| Headache |
0.9% |
| Multiple Sclerosis |
0.9% |
| Developmental Delay |
0.6% |
| Hypoproteinaemia |
0.6% |
| Immunosuppression |
0.6% |
| Acute Graft Versus Host Disease |
0.4% |
| Antibody Test Negative |
0.4% |
|
| Herpes Simplex Serology Positive |
16.3% |
| Transmission Of An Infectious Agent Via A Medicinal Product |
11.9% |
| Hepatitis B Surface Antigen Positive |
7.9% |
| Weight Decreased |
5.7% |
| Vasculitis |
5.3% |
| Pain In Extremity |
4.8% |
| Wheezing |
4.8% |
| Blood Glucose Increased |
4.4% |
| Hepatic Steatosis |
4.4% |
| Meningitis Aseptic |
4.4% |
| Treatment Noncompliance |
3.5% |
| Convulsion |
3.1% |
| Neurological Symptom |
3.1% |
| Pruritus Generalised |
3.1% |
| Thrombosis |
3.1% |
| Vomiting |
3.1% |
| Wrong Technique In Drug Usage Process |
3.1% |
| Death |
2.6% |
| Dyspnoea |
2.6% |
| Nausea |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
48.1% |
| Immunodeficiency Common Variable |
13.2% |
| Hypertension |
4.7% |
| Gastrooesophageal Reflux Disease |
3.9% |
| Product Used For Unknown Indication |
3.9% |
| Chronic Obstructive Pulmonary Disease |
3.1% |
| Multiple Allergies |
3.1% |
| Premedication |
2.3% |
| Anxiety |
1.6% |
| Asthma |
1.6% |
| Chronic Lymphocytic Leukaemia |
1.6% |
| Convulsion |
1.6% |
| Crohn's Disease |
1.6% |
| Hypothyroidism |
1.6% |
| Immunodeficiency |
1.6% |
| Menopause |
1.6% |
| Migraine |
1.6% |
| Restless Legs Syndrome |
1.6% |
| Selective Igg Subclass Deficiency |
1.6% |
| Blood Cholesterol Abnormal |
0.8% |
|
| Vomiting |
24.0% |
| Death |
8.0% |
| Dyspnoea |
8.0% |
| Oxygen Saturation Decreased |
8.0% |
| Cough |
4.0% |
| Crohn's Disease |
4.0% |
| Drug Ineffective |
4.0% |
| Herpes Simplex Serology Positive |
4.0% |
| Hypersensitivity |
4.0% |
| Lip Swelling |
4.0% |
| Malaise |
4.0% |
| Renal Pain |
4.0% |
| Speech Disorder |
4.0% |
| Thrombocytopenia |
4.0% |
| Urticaria |
4.0% |
| Vulvovaginitis Streptococcal |
4.0% |
| Weight Increased |
4.0% |
|
